No Data
AK MEDICAL (01789.HK) plans to hold a Board of Directors meeting on March 26 to approve the annual performance.
On March 11, Gronghui announced that AK MEDICAL (01789.HK) will hold a Board of Directors meeting on Wednesday, March 26, 2025, at the JW Business Center Executive Meeting Room, LG Level, Hong Kong Marriott International, located at 88 Gloucester Road, Admiralty, Hong Kong, to consider and approve the group's full-year performance for the year ending December 31, 2024, propose a final dividend (if any), and address any Other matters.
AK MEDICAL: DATE OF BOARD MEETING
AK Medical Holdings Limited's (HKG:1789) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
The new drug development time is cut in half, diagnoses are more accurate, industry barriers are lowered... AI is transforming the Medical Industry in China.
On February 26, Deutsche Bank Analyst Cyrus Ng released a report stating that the entire Medical Industry in China, from drug development and diagnostics to Hospital management, will benefit from the AI revolution.
The wave of AI in Medical is sweeping: the potential of the macromolecule new drug market is highlighted and imaging products are "going overseas" into Emerging Markets | Focus
① Some executives from pharmaceutical companies have stated that "currently, the discovery of small molecule drugs is very challenging; finding potential molecules and structures is already quite difficult, while there is still significant potential in the discovery and design of large molecule new drugs." ② Currently, the application maturity of AI technology in the imaging field is relatively high, and relevant manufacturers have revealed that the market potential for AI imaging large models in Belt and Road Initiative Concept countries is quite extensive.
Guosen: Focus on AI + Medical, high-quality innovation, and value symbols with stable performance.
Guosen remains bullish on companies with differentiated innovation capabilities and overseas potential.
